Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | ACE | P12821 | 2/20 | 0.42 |
| ▸ | F2R | P25116 | 2/20 | 0.41 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.40 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.40 |
| ▸ | CALCR | P30988 | 3/20 | 0.40 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.40 |
| ▸ | APLNR | P35414 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL417341 | 1.00 | OPRK1 (0.44) | OPRK1ACEF2RNTSR2NTSR1 | |
| SCHEMBL416570 | 0.95 | OPRK1 (0.45) | OPRK1ACEF2RNTSR2NTSR1 | |
| SCHEMBL416569 | 0.95 | OPRK1 (0.45) | OPRK1ACEF2RNTSR2NTSR1 | |
| SCHEMBL416535 | 0.94 | OPRK1 (0.46) | OPRK1ACEF2RNTSR2NTSR1 | |
| SCHEMBL416536 | 0.94 | OPRK1 (0.46) | OPRK1ACEF2RNTSR2NTSR1 | |
| SCHEMBL417518 | 0.93 | OPRM1 (0.45) | NTSR2NTSR1CALCRCXCR4APLNR | |
| SCHEMBL417517 | 0.93 | OPRM1 (0.45) | NTSR2NTSR1CALCRCXCR4APLNR | |
| SCHEMBL416629 | 0.90 | OPRK1 (0.55) | OPRK1ACECALCR | |
| SCHEMBL416628 | 0.90 | OPRK1 (0.55) | OPRK1ACECALCR | |
| SCHEMBL414730 | 0.88 | NTSR2 (0.48) | NTSR2NTSR1APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120020878-A1 | FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2012-01-26 | — | — | US | disclosed |